#UromigosLive24 Radioligands Part 1: VISION and PSMAFore Discussion

(28:27)

#UromigosLive24 Radioligands Part 2: SPLASH Results from ESMO 2024

(4:50)

#UromigosLive24: Radioligands Part 3: UpFront PSMA Results from ESMO 2024

(6:31)

#UromigosLive24 Radioligands Part 4: PEACE-3 Results from ESMO 2024

(11:13)

#UromigosLive24 Radioligands Part 5: Novel Radioligands in CRPC

(4:48)

Radioligands: Uromigos Live 2024

(54:10)

T-Minus 5 Days Until #UromigosLive24!

(1:40)

Challenges in radioligand therapy for patients with mCRPC

(1:47)

Radioligands in the future of prostate cancer treatment

(1:49)

Radioligand therapy advancements in prostate cancer

(2:4)

Radioligand therapy for mCRPC

(2:18)

Dr George on Other Potential Roles for Radioligand Therapy in Prostate Cancer

(3:2)

ARROW: PSMA-targeted radioligand therapy plus enzalutamide in mCRPC

(2:45)

Remaining questions regarding PSMA radioligand therapies

(44)

PCa Commentary May 2021 - PSMA Targeted RadioIigand Therapy for Metastatic Prostate Cancer

(2:35)

Targeted Radioligand Therapy for PSMA+, Metastatic Castration-Resistant Prostate Cancer

(4:28)

1st Radioligand therapy (RLT) approved in Europe

(1:18)

Anecdote de Claude Poirier au micro de Marie-Louise Arsenault | Tout peut arriver

(1:40)